Search results
Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors - ET HealthWorld |...
The Economic Times· 4 days agoEmcure Pharma: The pharma firm has decided to allot 57.8 lakh equity shares to 48 funds at Rs 1,008...
Emcure Pharmaceuticals IPO: Bain Capital backed firm raises ₹582 crore from anchor investors ahead...
Livemint· 4 days agoAccording to the exchange filing, the company has allocated 57,79,850 shares to 48 anchor investors...
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 6 days agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Bain’s India lender plans to double portfolio ahead of listing
CNBC Awaaz· 3 days agoTyger Capital Pvt Ltd., the Indian shadow lender Bain Capital bought from the Adani Group, is...
Emcure Pharma IPO Opens Today: Should You Subscribe? Check Price, GMP, Lot Size, Recommendations -...
News18· 4 days agoEmcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by ...
Bain-backed Emcure Pharma attracts bids worth $11 bn in IPO
VCCircle· 1 day agoVCCircle is India leading source Latest Indian Financial News,Startup Funding,Real Estate,Funding...
Tyger Capital to list by next year, targets Rs 20,000 crore book
Business Standard India· 2 days agoTyger Capital: Gaurav Gupta said that in keeping with growing business, company expects to take on...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 4 days agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Aavas Financiers: Big-bang stake sale brewing as Kedaara, Partners Group explore full exit
CNBC Awaaz· 3 days agoA mega stake sale is in the works at Aavas Financiers Ltd (formerly known as AU Housing Finance...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 2 days agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...